Ads
related to: glaxosmithkline products- TUKYSA® (tucatinib)
Treatment Option
FDA Approved
- What is TUKYSA®?
Benefits of Treatment
Learn More Here Today
- Patient Brochure
Learn about TUKYSA®
Explore More Here
- Explore FAQs Here
TUKYSA® (tucatinib) tablets
Frequently Asked Questions
- Important Safety Info
View Safety Information
For TUKYSA® (tucatinib) tablets
- Patient Resources
Read About TUKYSA®
Download Brochure & More
- TUKYSA® (tucatinib)
Search results
FTSE 100: GSK tops forecasts after strong sales of shingles vaccine
Yahoo Finance UK· 1 year agoGSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado...
GSK India arm's Q3 profit falls on government price cap
Reuters via Yahoo Finance· 2 months agoGlaxoSmithKline Pharmaceuticals, the Indian unit of the UK's GSK, reported a 3% fall in...
Texas Pete isn’t plaintiff’s 1st class action lawsuit. Here’s how 3 others went
WDAF via Yahoo News· 8 months ago(WGHP) — The Texas Pete lawsuit isn’t California man Phillip White’s first rodeo. On Sept. 12,...
Popular asthma inhaler will be discontinued Jan. 1. Here’s what users should know
Miami Herald via Yahoo News· 4 months agoPeople using the popular corticosteroid inhalers Flovent HFA or Flovent Diskus to treat their asthma...
Shingles Vaccine Market is Booming in Near Future 2023-2031
NewMediaWire via Yahoo Finance· 1 year agoPune, India - (NewMediaWire) - March 3, 2023 - "Shingles Vaccine" Size, Scope, and Forecast...
12 Best Ethical Stocks To Buy Now
Insider Monkey via Yahoo Finance· 2 years agoIn this article, we will take a look at 12 best ethical stocks to buy now. If you want to see some more of the best ethical stocks to buy, go directly to...
3 High Dividend Stocks With Attractive Total Return Potential
InvestorPlace via Yahoo Finance· 1 year agoIn the current economic climate of rising interest rates, persistent inflation, simmering...
GSK consumer spin-off Haleon floats in biggest London listing in a decade
The Independent via Yahoo News· 2 years agoGlaxoSmithKline’s consumer spin-off Haleon has floated on the London Stock Exchange in Europe’s...
AstraZeneca follows rival, will cap inhaler prices at $35 per month amid scrutiny
WJZY via Yahoo News· 1 month ago(The Hill) — Drugmaker AstraZeneca will cap out-of-pocket costs at $35 for all its inhaler products,...
GSK Key Drugs & Vaccines Help Stock Outperform Industry YTD
Zacks via Yahoo Finance· 5 months agoStrong sales growth of GSK's specialty drugs and vaccines, the contribution from new products and...